Urothelial cancer
71 – 80 of 126
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Immunohistochemical Assays for Bladder Cancer Molecular Subtyping : Optimizing Parsimony and Performance of Lund Taxonomy Classifiers
- Contribution to journal › Article
-
Mark
Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men
- Contribution to journal › Article
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
- Contribution to journal › Published meeting abstract
-
Mark
Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer
- Contribution to journal › Article
-
Mark
Re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy Have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029 : A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy
- Contribution to journal › Letter
- 2021
-
Mark
Tumor Subtyping : Making Sense of Heterogeneity with a Goal Toward Treatment
- Contribution to journal › Scientific review
-
Mark
multiclassPairs: An R package to train multiclass pair-based classifier
- Contribution to journal › Debate/Note/Editorial
-
Mark
Personalized medicine for bladder cancer
- Contribution to journal › Article
-
Mark
Association Between Estrogen Receptors and GATA3 in Bladder Cancer : A Systematic Review and Meta-Analysis of Their Clinicopathological Significance
- Contribution to journal › Scientific review
-
Mark
Urinary diversions for benign and oncologic indications: what did we learn about short term complications in the last 24 months?
- Contribution to journal › Article
